Mito-FLAG with Ara-C as Bolus Vs. Continuous Infusion in Recurrent AML – Results of a Prospective Randomized Intergroup Study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemias (SAL)
暂无分享,去创建一个
D. Niederwieser | G. Ehninger | W. Aulitzky | A. Hänel | M. Wilhelm | K. Schaefer-Eckart | F. Kroschinsky | M. Hanel | R. Herbst | N. Peter | F. Fiedler | S. Neugebauer | W. Poenisch | K. Friedrichsen